| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000032493 |
| Receipt No. | R000037056 |
| Official scientific title of the study | Whole-genome sequencing and comprehensive variant analysis of combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC |
| Date of disclosure of the study information | 2018/06/01 |
| Last modified on | 2018/05/07 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Whole-genome sequencing and comprehensive variant analysis of combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC | |
| Title of the study (Brief title) | Whole-genome sequencing and comprehensive variant analysis of HCC with cancer stem cell features | |
| Region |
|
|
| Condition | ||
| Condition | hepatocellular carcinoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To analyse the genomic mutation in combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC
To confirm the relation between the genomic mutation and the clinicopathological features To speculate the evolutionary changes in HCC carcinogenetic pathway |
| Basic objectives2 | Others |
| Basic objectives -Others | Genetic analysis |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The relation between the genomic mutation and the clinicopathological features in combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCC |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Cases in which surgical resection for HCC were performed from Jan 2007 until Dec 2017 at Kyoto University Hospital and meet both of the conditions below.
(1) 20 years or older (2) pathologically diagnosed with HCC |
|||
| Key exclusion criteria | Cases in which written informed consent was not obtained | |||
| Target sample size | 600 | |||
| Research contact person | |
| Name of lead principal investigator | Takamichi Ishii |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Department of Surgery (Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery) |
| Address | Shogoinkawaharacho 54, Sakyo-ku, Kyoto |
| TEL | 075-751-3242 |
| taishii@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroshi Kawamoto |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Department of Surgery (Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery) |
| Address | Shogoinkawaharacho 54, Sakyo-ku, Kyoto |
| TEL | 075-751-3242 |
| Homepage URL | |
| hrkawamoto@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Society for the Promotion of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037056 |